The store will not work correctly when cookies are disabled.
2-(3-methyl-1H-pyrazol-4-yl)-N-(1-methylcyclopropyl)pyrido[3,4-d]pyrimidin-4-amine
ID: ALA4585067
PubChem CID: 137350911
Max Phase: Preclinical
Molecular Formula: C15H16N6
Molecular Weight: 280.34
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1n[nH]cc1-c1nc(NC2(C)CC2)c2ccncc2n1
Standard InChI: InChI=1S/C15H16N6/c1-9-11(7-17-21-9)13-18-12-8-16-6-3-10(12)14(19-13)20-15(2)4-5-15/h3,6-8H,4-5H2,1-2H3,(H,17,21)(H,18,19,20)
Standard InChI Key: HQFDCITUHVQXEV-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 24 0 0 0 0 0 0 0 0999 V2000
8.2627 -11.8699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4455 -11.8699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8541 -12.5776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1740 -14.7507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2668 -15.5602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0668 -15.7270 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9234 -14.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4699 -15.0194 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6211 -13.5290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6199 -14.3527 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3321 -14.7616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3303 -13.1160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0431 -13.5254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0438 -14.3486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7565 -14.7556 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4647 -14.3448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4600 -13.5185 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7509 -13.1111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7466 -12.2898 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6631 -16.1110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4314 -11.0528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
1 3 1 0
4 5 1 0
5 6 2 0
6 8 1 0
7 4 2 0
7 8 1 0
9 10 2 0
10 11 1 0
11 14 2 0
13 12 2 0
12 9 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
18 19 1 0
19 2 1 0
16 4 1 0
5 20 1 0
2 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 280.34 | Molecular Weight (Monoisotopic): 280.1436 | AlogP: 2.69 | #Rotatable Bonds: 3 |
Polar Surface Area: 79.38 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.06 | CX Basic pKa: 2.92 | CX LogP: 1.83 | CX LogD: 1.83 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.77 | Np Likeness Score: -0.98 |
References
1. (2018) 6-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS Inhibitors, |